
    
      This was a prospective, multi-center, randomized, open-label study with blinded raters to
      evaluate the effects of immediate versus delayed switch to carbidopa/levodopa/entacapone on
      motor function and quality of life in patients with Parkinson's disease with end-of-dose
      wearing off.
    
  